2012
The promise and pitfalls of mass drug administration to control intestinal helminth infections
Humphries D, Nguyen S, Boakye D, Wilson M, Cappello M. The promise and pitfalls of mass drug administration to control intestinal helminth infections. Current Opinion In Infectious Diseases 2012, 25: 584-589. PMID: 22903231, DOI: 10.1097/qco.0b013e328357e4cf.Peer-Reviewed Original ResearchConceptsMass drug administrationIntestinal helminth infectionsHelminth infectionsDrug AdministrationSoil-transmitted nematode infectionsIntensity of schistosomiasisHigh-risk groupResource-limited settingsLong-term controlSignificant morbidityPregnant womenLong-term benefitsNew drug developmentIntensity of infectionIntestinal helminthsEndemic areasConsistent benefitInfectionChemotherapeutic interventionCertain populationsDrug developmentBenzimidazole anthelminthicsIntensive monitoringPrevalenceAdministration
2004
Hookworm infection: molecular mechanisms of disease and targets for control
Jones B, Cappello M. Hookworm infection: molecular mechanisms of disease and targets for control. Drug Discovery Today Disease Mechanisms 2004, 1: 217-222. DOI: 10.1016/j.ddmec.2004.10.004.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsHookworm anaemiaSmall intestineMajor global health problemStage of diseaseGlobal health problemProtein-energy malnutritionVirulence factorsMolecular mechanismsPregnant womenSevere anemiaVaccine strategiesPlatelet inhibitorsPancreatic digestive enzymesHealth burdenEnergy malnutritionHost small intestineHealth problemsGrowth delayAnemiaHookworm diseaseIntestinal nematodesDisease controlChild mortalityMount Sinai SchoolPotential target